103 related articles for article (PubMed ID: 37282766)
1. SARS-CoV-2 Omicron (B.1.1.529) infection in rhesus macaques, hamsters, and BALB/c mice with severe lung histopathological damage.
Yu W; Wang J; Yang Y; Tang C; Yang C; Li B; Wang H; Zhou Y; Huang Q; Yang H; Wu D; Luo Z; Gao J; Kuang D; Long H; Peng X; Xie Z; Lu S
J Med Virol; 2023 Jun; 95(6):e28846. PubMed ID: 37282766
[TBL] [Abstract][Full Text] [Related]
2. [Comparative study of Wuhan-like and omicron-like variants of SARS-CoV-2 in experimental animal models].
Leneva IA; Smirnova DI; Kartashova NP; Gracheva AV; Ivanina AV; Glubokova EA; Korchevaya ER; Pancratov AA; Trunova GV; Khokhlova VA; Svitich OA; Zverev VV; Faizuloev EB
Vopr Virusol; 2022 Nov; 67(5):439-449. PubMed ID: 36515289
[TBL] [Abstract][Full Text] [Related]
3. Impact of Reinfection with SARS-CoV-2 Omicron Variants in Previously Infected Hamsters.
Shiwa-Sudo N; Sakai Y; Iwata-Yoshikawa N; Watanabe S; Yamada S; Kuroda Y; Yamamoto T; Shirakura M; Fujisaki S; Miyazaki K; Miura H; Nagata S; Fukushi S; Maeda K; Hasegawa H; Suzuki T; Nagata N
J Virol; 2023 Jan; 97(1):e0136622. PubMed ID: 36633406
[TBL] [Abstract][Full Text] [Related]
4. Pathogenicity of SARS-CoV-2 Omicron (R346K) variant in Syrian hamsters and its cross-neutralization with different variants of concern.
Mohandas S; Yadav PD; Sapkal G; Shete AM; Deshpande G; Nyayanit DA; Patil D; Kadam M; Kumar A; Mote C; Jain R
EBioMedicine; 2022 May; 79():103997. PubMed ID: 35405385
[TBL] [Abstract][Full Text] [Related]
5. The omicron (B.1.1.529) SARS-CoV-2 variant of concern does not readily infect Syrian hamsters.
Abdelnabi R; Foo CS; Zhang X; Lemmens V; Maes P; Slechten B; Raymenants J; André E; Weynand B; Dallmeier K; Neyts J
Antiviral Res; 2022 Feb; 198():105253. PubMed ID: 35066015
[TBL] [Abstract][Full Text] [Related]
6. Reduced pathogenicity of the SARS-CoV-2 omicron variant in hamsters.
McMahan K; Giffin V; Tostanoski LH; Chung B; Siamatu M; Suthar MS; Halfmann P; Kawaoka Y; Piedra-Mora C; Jain N; Ducat S; Kar S; Andersen H; Lewis MG; Martinot AJ; Barouch DH
Med; 2022 Apr; 3(4):262-268.e4. PubMed ID: 35313451
[TBL] [Abstract][Full Text] [Related]
7. Characterization of Three Variants of SARS-CoV-2 In Vivo Shows Host-Dependent Pathogenicity in Hamsters, While Not in K18-hACE2 Mice.
Toomer G; Burns W; Garcia L; Henry G; Biancofiori A; George A; Duffy C; Chu J; Sides M; Muñoz M; Garcia K; Nikolai-Yogerst A; Peng X; Westfall L; Baker R
Viruses; 2022 Nov; 14(11):. PubMed ID: 36423193
[TBL] [Abstract][Full Text] [Related]
8. A novel RBD-protein/peptide vaccine elicits broadly neutralizing antibodies and protects mice and macaques against SARS-CoV-2.
Wang S; Wang CY; Kuo HK; Peng WJ; Huang JH; Kuo BS; Lin F; Liu YJ; Liu Z; Wu HT; Ding S; Hou KL; Cheng J; Yang YT; Jiang MH; Wang MS; Chen T; Xia WG; Lin E; Hung CH; Chen HJ; Shih Z; Lin YL; Ryan V; Hu MM; Heppner DG; Malherbe DC; Periasamy S; Kuzmina N; Subramani C; Hellerstein M; Monath TP; Rumyantsev A; Bukreyev A; Guirakhoo F
Emerg Microbes Infect; 2022 Dec; 11(1):2724-2734. PubMed ID: 36287714
[TBL] [Abstract][Full Text] [Related]
9. Intranasal Boosting with Spike Fc-RBD of Wild-Type SARS-CoV-2 Induces Neutralizing Antibodies against Omicron Subvariants and Reduces Viral Load in the Nasal Turbinate of Mice.
Cai JP; Luo C; Wang K; Cao H; Chen LL; Zhang X; Han Y; Yin F; Zhang AJ; Chu H; Yuan S; Kok KH; To KK; Chen H; Chen Z; Jin DY; Yuen KY; Chan JF
Viruses; 2023 Mar; 15(3):. PubMed ID: 36992395
[TBL] [Abstract][Full Text] [Related]
10. Nasal Mucosa Exploited by SARS-CoV-2 for Replicating and Shedding during Reinfection.
Li H; Zhao X; Li J; Zheng H; Zhao Y; Yang J; Zhou J; Yang F; Chen Y; Zuo Y; Lai Q; Long H; Li Y; Jin W; Shi H; Liu L
Viruses; 2022 Jul; 14(8):. PubMed ID: 35893674
[TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters.
Halfmann PJ; Iida S; Iwatsuki-Horimoto K; Maemura T; Kiso M; Scheaffer SM; Darling TL; Joshi A; Loeber S; Singh G; Foster SL; Ying B; Case JB; Chong Z; Whitener B; Moliva J; Floyd K; Ujie M; Nakajima N; Ito M; Wright R; Uraki R; Warang P; Gagne M; Li R; Sakai-Tagawa Y; Liu Y; Larson D; Osorio JE; Hernandez-Ortiz JP; Henry AR; Ciuoderis K; Florek KR; Patel M; Odle A; Wong LR; Bateman AC; Wang Z; Edara VV; Chong Z; Franks J; Jeevan T; Fabrizio T; DeBeauchamp J; Kercher L; Seiler P; Gonzalez-Reiche AS; Sordillo EM; Chang LA; van Bakel H; Simon V; ; Douek DC; Sullivan NJ; Thackray LB; Ueki H; Yamayoshi S; Imai M; Perlman S; Webby RJ; Seder RA; Suthar MS; García-Sastre A; Schotsaert M; Suzuki T; Boon ACM; Diamond MS; Kawaoka Y
Nature; 2022 Mar; 603(7902):687-692. PubMed ID: 35062015
[TBL] [Abstract][Full Text] [Related]
12. The Omicron Variant BA.1.1 Presents a Lower Pathogenicity than B.1 D614G and Delta Variants in a Feline Model of SARS-CoV-2 Infection.
Martins M; do Nascimento GM; Nooruzzaman M; Yuan F; Chen C; Caserta LC; Miller AD; Whittaker GR; Fang Y; Diel DG
J Virol; 2022 Sep; 96(17):e0096122. PubMed ID: 36000850
[TBL] [Abstract][Full Text] [Related]
13. Replicating RNA platform enables rapid response to the SARS-CoV-2 Omicron variant and elicits enhanced protection in naïve hamsters compared to ancestral vaccine.
Hawman DW; Meade-White K; Clancy C; Archer J; Hinkley T; Leventhal SS; Rao D; Stamper A; Lewis M; Rosenke R; Krieger K; Randall S; Khandhar AP; Hao L; Hsiang TY; Greninger AL; Gale M; Berglund P; Fuller DH; Rosenke K; Feldmann H; Erasmus JH
EBioMedicine; 2022 Sep; 83():104196. PubMed ID: 35932641
[TBL] [Abstract][Full Text] [Related]
14. A Heterologous Challenge Rescues the Attenuated Immunogenicity of SARS-CoV-2 Omicron BA.1 Variant in Syrian Hamster Model.
Ma J; Liu X; Zhou M; Chen P; Chen R; Wang J; Zhu H; Wu K; Ye J; Zhang Y; Yuan Q; Tang Q; Yuan L; Cheng T; Guan Y; Xia N
J Virol; 2023 Feb; 97(2):e0168422. PubMed ID: 36651747
[TBL] [Abstract][Full Text] [Related]
15. Infection, pathology and interferon treatment of the SARS-CoV-2 Omicron BA.1 variant in juvenile, adult and aged Syrian hamsters.
Yuan L; Zhu H; Chen P; Zhou M; Ma J; Liu X; Wu K; Chen R; Liu Q; Yu H; Li L; Wang J; Zhang Y; Ge S; Yuan Q; Tang Q; Cheng T; Guan Y; Xia N
Cell Mol Immunol; 2022 Dec; 19(12):1392-1399. PubMed ID: 36258005
[TBL] [Abstract][Full Text] [Related]
16. Genes involved in the limited spread of SARS-CoV-2 in the lower respiratory airways of hamsters may be associated with adaptive evolution.
Takada K; Orba Y; Kida Y; Wu J; Ono C; Matsuura Y; Nakagawa S; Sawa H; Watanabe T
J Virol; 2024 May; 98(5):e0178423. PubMed ID: 38624229
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary lesions following inoculation with the SARS-CoV-2 Omicron BA.1 (B.1.1.529) variant in Syrian golden hamsters.
Rissmann M; Noack D; van Riel D; Schmitz KS; de Vries RD; van Run P; Lamers MM; Geurts van Kessel CH; Koopmans MPG; Fouchier RAM; Kuiken T; Haagmans BL; Rockx B
Emerg Microbes Infect; 2022 Dec; 11(1):1778-1786. PubMed ID: 35787236
[TBL] [Abstract][Full Text] [Related]
18. A variant-proof SARS-CoV-2 vaccine targeting HR1 domain in S2 subunit of spike protein.
Pang W; Lu Y; Zhao YB; Shen F; Fan CF; Wang Q; He WQ; He XY; Li ZK; Chen TT; Yang CX; Li YZ; Xiao SX; Zhao ZJ; Huang XS; Luo RH; Yang LM; Zhang M; Dong XQ; Li MH; Feng XL; Zhou QC; Qu W; Jiang S; Ouyang S; Zheng YT
Cell Res; 2022 Dec; 32(12):1068-1085. PubMed ID: 36357786
[TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 Omicron variant causes mild pathology in the upper and lower respiratory tract of hamsters.
Armando F; Beythien G; Kaiser FK; Allnoch L; Heydemann L; Rosiak M; Becker S; Gonzalez-Hernandez M; Lamers MM; Haagmans BL; Guilfoyle K; van Amerongen G; Ciurkiewicz M; Osterhaus ADME; Baumgärtner W
Nat Commun; 2022 Jun; 13(1):3519. PubMed ID: 35725735
[TBL] [Abstract][Full Text] [Related]
20. Mucosal immunization with Ad5-based vaccines protects Syrian hamsters from challenge with omicron and delta variants of SARS-CoV-2.
Braun MR; Martinez CI; Dora EG; Showalter LJ; Mercedes AR; Tucker SN
Front Immunol; 2023; 14():1086035. PubMed ID: 36911687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
